How is the Invasive Fungal Infections Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the Invasive Fungal Infections market size evolved in recent years?
There has been a steady increase in the market size of invasive fungal infections in the past few years. This market is projected to rise from $7.58 billion in 2024, to $7.96 billion in 2025, with a compound annual growth rate (CAGR) of 5.0%. This growth throughout the historical period can be credited to factors such as the worldwide proliferation of infections, hematopoietic stem cell transplants, the aging population, hospital-borne infections, and environmental factors.
What are the predictions for the invasive fungal infections market size in the coming years?
The market size of invasive fungal infections is projected to experience consistent expansion in the forthcoming years, with an estimation to reach $9.6 billion by 2029, at a compound annual growth rate (CAGR) of 4.8%. The expected growth during the forecast period can be credited to preparedness for global health scenarios, education about public health, new antifungal agents, the impact of climate change, and combined disciplinary approaches. Main projected trends during this period will be improvements in diagnostic technologies, personalized therapeutic strategies, patient-focused care, combined antifungal therapies, and partnerships for drug innovation.
Get your invasive fungal infections market report here!
https://www.thebusinessresearchcompany.com/report/invasive-fungal-infections-global-market-report
What key factors are fueling the growth of the invasive fungal infections market?
The invasive fungal infection market is projected to grow due to an increase in the number of people living with the human immunodeficiency virus (HIV). HIV impairs the immune system’s ability to fight diseases, thus increasing susceptibility to invasive fungal infections. This provides a window of opportunity for manufacturers to evolve and produce more effective antifungal drugs. UNAIDS reported in July 2023 that the worldwide HIV-infected population rose to 39 million in 2022, marking an increase of 3.17% from 37.7 million in 2020. About 1.3 million new instances of HIV were documented in 2022. The surge in people affected by HIV is thus fuelling the growth of the invasive fungal infection market.
Driving Force of Invasive Fungal Infections Market: Growth Fueled by Surge in Cancer Patients
How is the global invasive fungal infections market divided into key segments?
The invasive fungal infections market covered in this report is segmented –
1) By Disease Type: Candidemia And Invasive Candidiasis, Intra Abdominal Candidiasis, Cryptococcal Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Other Disease Type
2) By Drug Type: Polyenes, Triazoles, Echinocandins, Flucytosine, Other Drug Type
3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Candidemia And Invasive Candidiasis: Bloodstream Infections, Disseminated Candidiasis
2) By Intra-Abdominal Candidiasis: Peritoneal Candidiasis, Abscess Formation
3) By Cryptococcal Meningitis: Primary Cryptococcal Meningitis, Secondary Cryptococcal Meningitis
4) By Esophageal Candidiasis: Acute Esophageal Candidiasis, Chronic Esophageal Candidiasis
5) By Histoplasmosis Acute Pulmonary: Disseminated Histoplasmosis, Chronic Pulmonary Histoplasmosis
6) By Other Disease Types: Aspergillosis, Mucormycosis, Other Rare Fungal Infections
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13189&type=smp
Who are the key firms paving the way for growth in the invasive fungal infections market?
Major companies operating in the invasive fungal infections market report are Pfizer Inc., Merck And Co. Inc., Bayer AG, Abbott Laboratories, GSK PLC, Gilead Sciences Inc., Siemens Healthineers, Mylan N.V., Astellas Pharma Inc., Quest Diagnostics Incorporated, Sun Pharmaceutical Industries Ltd., BioMérieux SA, BioMarin Pharmaceutical Inc., Xellia Pharmaceuticals, Basilea Pharmaceutica, Cidara Therapeutic Inc., Pulmocide Ltd., NovaBiotics Ltd., F2G Ltd., Giner Inc., Ciron Drugs And Pharmaceuticals Pvt. Ltd., Hexima Limited, Scynexis Inc., Enzon Pharmaceuticals Inc., Matinas BioPharma Holdings Inc., Biosergen AB
Which trends are expected to transform the invasive fungal infections market?
Key players in the invasive fungal infection market, such as BDR Pharmaceuticals, are concentrating on the development of innovative products like Zisavel capsules. The objective is to improve the effectiveness of treatments, boost the patient prognosis, and widen the scope for individuals afflicted with severe fungal infections. Derived from isavuconazole, Zisavel capsules are a standard antifungal drug utilized in treating invasive aspergillosis and mucormycosis. The focus of this 100 mg capsule edition is to offer a cost-friendly alternative for patients, hence expanding the reach of effective therapy. For example, BDR Pharmaceuticals, a company specializing in generic drugs based in India, launched these generic antifungal capsules to treat invasive aspergillosis and mucormycosis in October 2023. Zisavel is used to handle invasive aspergillosis and mucormycosis, both serious and potentially fatal fungal infections. The goal of introducing Zisavel is to make the treatment more accessible by substantially reducing the price, compared to existing alternatives like voriconazole and posaconazole.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13189
What regions are contributing significantly to the growth of the invasive fungal infections market?
North America was the largest region in the invasive fungal infections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the invasive fungal infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
In Vitro Diagnostics (IVD) Quality Control Global Market Report 2024
Veterinary Infectious Disease Diagnostics Global Market Report 2024
Hepatitis B Virus (HBV) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
